Richard Grable (Deceased)
Mr. Richard Grable Ph.D. was a Founder of Imaging Diagnostic Systems and Inventor of the CTLM device. He was considered a pioneer in the Optical Imaging field with over 25 years experience. He had over 30 years of electronic design experience and was directly involved in the development and sales of CT, Nuclear Medicine and Ultrasound instrumentation since 1972. Mr. Grable had over 16 years of experience of preparing and filing Investigation Device exemption applications(IDE), 510(K)’s and PreMarket Approval Applications(PMA) for the US Food and Drug Administration. He was awarded 9 United State patent in his name and was co-inventor of another medical device.
He was a member of the Institute of Electrical & Electronics Engineers, Optical Society of America, the American Association for the Advancement of Science, the New York Academy of Science, and the International Society for Optical Engineering. He was a graduate of the University of Miami School of Business with a Masters Degree in Business Administration.
Linda B. Grable
Mrs. Grable is a Founder and significant shareholder of Imaging Diagnostic Systems, Inc. During her tenure, Mrs. Grable was pivotal in raising over 52 million dollars in equity funding for the research and development of the CTLM system.
A graduate of Ohio State University with a BA degree in Journalism and Marketing, she had over 30 years of experience in financial negotiations for both medical and real estate development businesses. In addition, she had over 20 years of executive experience in the medical device industry, for both sales and marketing in the U.S. and foreign countries
IMDS Details
Imaging Diagnostic Systems, Inc., a development stage medical technology company, engages in commercializing medical imaging equipment worldwide. The company offers computed tomography laser mammography (CTLM) for detecting breast cancer.
CTLM is an imaging modality offering the potential of molecular functional imaging, which could visualize the process of angiogenesis and might be used to distinguish between benign and malignant tissue. It is designed to be used in conjunction with mammography.
CTLM also reveals information about blood distribution in the breast. The company installed its CTLM system in Italy, Germany, Poland, the Czech Republic, the Peoples Republic of China, Malaysia, and the United Arab Emirates. It also offers ‘Laser Imager for Lab Animals (LILA)’, an optical helical micro-CT scanner that is designed to image numerous compounds, primarily green fluorescent protein, derived from the DNA of jellyfish. The LILA scanner is targeted at pharmaceutical developers and researchers who monitor cancer growth and who use multimodality small animal imaging in their clinical research.
The company was founded in 1993 and is headquartered in Plantation, Florida.